Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer
Abstract Purpose Hormone receptor-positive breast cancer is characterized by the expression of estrogen receptor (ER) or progesterone receptor (PR), it is generally associated with less aggressive clinical features and more favorable prognostic outcomes, primarily due to the effectiveness of endocri...
Saved in:
| Main Authors: | Zhengjia Lu, Jiao Yang, Yang Feng, Jia Ming |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14451-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2023-09-01) -
Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01) -
Clinical and biological significance of estrogen receptor-positive/progesterone receptor-negative in invasive breast cancer: bioinformatic analysis
by: Maryam Althobiti, et al.
Published: (2025-05-01) -
Characteristics of endometrial receptivity in women with different endometrial thickness
by: N. V. Aganezova, et al.
Published: (2022-05-01) -
LYN kinase and estrogen receptor ERα: involvement in carcinogenesis and potential therapeutic target for tumors
by: V. V. Tikhonova, et al.
Published: (2021-11-01)